ES2182960T3 - Medio de contraste para la toma de imagenes in vivo basado en la transmision de la luz al reflejarse. - Google Patents

Medio de contraste para la toma de imagenes in vivo basado en la transmision de la luz al reflejarse.

Info

Publication number
ES2182960T3
ES2182960T3 ES96901441T ES96901441T ES2182960T3 ES 2182960 T3 ES2182960 T3 ES 2182960T3 ES 96901441 T ES96901441 T ES 96901441T ES 96901441 T ES96901441 T ES 96901441T ES 2182960 T3 ES2182960 T3 ES 2182960T3
Authority
ES
Spain
Prior art keywords
vivo
reflecting
transmission
light
picture based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901441T
Other languages
English (en)
Inventor
Jo Klaveness
Bjorn Fuglaas
Pal Rongved
Edvin Johannesen
Paul Mark Henrichs
Wolfgang Hans Heinrich Gunther
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Application granted granted Critical
Publication of ES2182960T3 publication Critical patent/ES2182960T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0015—Phosphorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0476—Particles, beads, capsules, spheres
    • A61K49/0485—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL EMPLEO DE MATERIALES CONSTITUIDOS POR PARTICULAS COMO AGENTES DE CONTRASTE EN IMAGENES DE LUZ IN VIVO.
ES96901441T 1995-02-02 1996-02-02 Medio de contraste para la toma de imagenes in vivo basado en la transmision de la luz al reflejarse. Expired - Lifetime ES2182960T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502065.7A GB9502065D0 (en) 1995-02-02 1995-02-02 Contrast media

Publications (1)

Publication Number Publication Date
ES2182960T3 true ES2182960T3 (es) 2003-03-16

Family

ID=10769008

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901441T Expired - Lifetime ES2182960T3 (es) 1995-02-02 1996-02-02 Medio de contraste para la toma de imagenes in vivo basado en la transmision de la luz al reflejarse.

Country Status (13)

Country Link
EP (1) EP0808175B1 (es)
JP (1) JP4155596B2 (es)
KR (2) KR19980701880A (es)
AU (1) AU4545896A (es)
BR (1) BR9607012A (es)
CA (1) CA2212257A1 (es)
DE (1) DE69622693T2 (es)
ES (1) ES2182960T3 (es)
FI (1) FI973208L (es)
GB (1) GB9502065D0 (es)
HU (1) HUP9900610A2 (es)
NO (1) NO973542L (es)
WO (1) WO1996023524A1 (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708265D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
WO1998048847A1 (en) * 1997-04-25 1998-11-05 Nycomed Imaging As Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization
JP2001526650A (ja) * 1997-04-29 2001-12-18 ニユコメド・イメージング・アクシエセルカペト 光画像造影剤
GB9712525D0 (en) * 1997-06-16 1997-08-20 Nycomed Imaging As Method
WO1999013916A2 (en) * 1997-09-18 1999-03-25 Nycomed Imaging As Methods and compositions for medical imaging
EP1096956A1 (en) * 1998-07-06 2001-05-09 Pharmacyclics, Inc. Intracellular sensitizers for sonodynamic therapy
CA2337361C (en) * 1998-07-13 2010-11-16 The Board Of Regents Of The University Of Nebraska Targeted site specific drug delivery compositions and method of use
KR100649035B1 (ko) * 1998-07-13 2006-11-24 더 보드 오브 리젠츠 오브 더 유니버시티 오브 네브라스카 표적화된 부위특이적 약물 송달 조성물 및 사용방법
EP1206288B1 (en) * 1999-08-02 2007-01-10 The Regents Of The University Of Michigan Targeted fiberless radiative effectors
US20050182434A1 (en) 2000-08-11 2005-08-18 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
US6915154B1 (en) 1999-09-24 2005-07-05 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
AU3679801A (en) * 2000-02-08 2001-08-20 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
WO2002034297A2 (en) * 2000-10-24 2002-05-02 Visys Ag Endoscopic vascular visualisation, diagnostic and/or surgical procedure
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
JP2002365219A (ja) * 2001-06-06 2002-12-18 Takara Keiki Seisakusho:Kk 搬送処理装置
TWI240632B (en) 2001-07-30 2005-10-01 Epix Medical Inc Purified peptides for peptide-based multimeric targeted contrast agents
EP1465590B1 (en) * 2001-11-02 2008-03-26 The Governors Of The University Of Alberta Micelle compositions containing pegylated phospholipids and a photosensitizer
ES2398393T3 (es) 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
ES2431520T3 (es) 2003-01-25 2013-11-26 Seno Medical Instruments, Inc. Procedimiento de formación de imágenes optoacústicas de contraste elevado utilizando nanopartículas no esféricas
ES2396368T3 (es) 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
JP2005220045A (ja) * 2004-02-04 2005-08-18 Konica Minolta Medical & Graphic Inc 蛍光造影剤
US20050259779A1 (en) * 2004-05-18 2005-11-24 Siemens Aktiengesellschaft Biomolecular contrast agents for therapy optimization in radiation therapy with proton or ion beams
US7585492B2 (en) 2004-05-18 2009-09-08 Siemens Aktiengesellschaft Biomolecular contrast agents for therapy success and dose monitoring in radiation therapy with proton or ion beams
US20060239921A1 (en) 2005-04-26 2006-10-26 Novadaq Technologies Inc. Real time vascular imaging during solid organ transplant
JP2009507208A (ja) 2005-05-27 2009-02-19 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム 細胞および組成物の光学コヒーレンス断層撮影法による検出
US8355776B2 (en) 2005-05-27 2013-01-15 Board Of Regents, The University Of Texas System Hemoglobin contrast in magneto-motive optical doppler tomography, optical coherence tomography, and ultrasound imaging methods and apparatus
US7801590B2 (en) 2005-05-27 2010-09-21 Board Of Regents, The University Of Texas System Optical coherence tomographic detection of cells and killing of the same
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
EP1991577A2 (en) 2006-01-31 2008-11-19 Parkinson, John F. Modulation of mdl-1 activity for treatment of inflammatory disease
ATE531199T1 (de) * 2006-04-03 2011-11-15 Given Imaging Ltd Vorrichtung, system und verfahren zur in-vivo- analyse
EP2054087A2 (en) 2006-07-06 2009-05-06 The Trustees of Columbia University in the City of New York Polychromatic, diversely-sized particles for angiography
KR100825939B1 (ko) * 2006-08-28 2008-04-29 한국과학기술연구원 근적외선 형광체가 결합된 양친성 고분자의 나노 입자를포함하는 암 진단용 조영제
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
CN101558081B (zh) 2006-12-11 2014-08-20 伯拉考成像股份公司 用于诊断和治疗应用的纤维蛋白结合肽缀合体
WO2009009786A2 (en) 2007-07-12 2009-01-15 Board Of Regents, The University Of Texas System Magneto-motive ultrasound detection of magnetic nanoparticles
EP2476703A1 (en) 2011-01-14 2012-07-18 Bracco Imaging S.p.A Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
EP3372250B1 (en) 2008-05-02 2019-12-25 Novadaq Technologies ULC Methods for production and use of substance-loaded erythrocytes for observation and treatment of microvascular hemodynamics
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
TWI499427B (zh) 2010-05-31 2015-09-11 衛材Ｒ＆Ｄ企管股份有限公司 Fluorescent probes for imaging lymph nodes
US9610367B2 (en) * 2010-08-24 2017-04-04 Canon Kabushiki Kaisha Particle and contrast agent having the particle
WO2012095516A1 (en) 2011-01-14 2012-07-19 Bracco Imaging Spa Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
WO2013121284A1 (en) * 2012-02-14 2013-08-22 Universite De Strasbourg Iodinated products intended for a use for the medical imaging and their methods of preparation
JP6028096B2 (ja) 2012-06-21 2016-11-16 ノバダック テクノロジーズ インコーポレイテッド 血管造影及びかん流の定量化並びに解析手法
KR101441792B1 (ko) * 2013-02-21 2014-09-17 가톨릭대학교 산학협력단 자성을 이용한 광 및 초음파 역학 치료용 캡슐 내시경
JP6549554B2 (ja) 2013-03-15 2019-07-24 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア コレステロール流出を刺激する、減少した毒性を有するペプチド
WO2015038968A1 (en) 2013-09-13 2015-03-19 The General Hospital Corporation Activatable fibrin-binding probes
KR101610465B1 (ko) * 2014-04-11 2016-04-07 국립암센터 다목적용 의료 영상 표지자 및 이의 제조방법
CN107209118B (zh) 2014-09-29 2021-05-28 史赛克欧洲运营有限公司 在自体荧光存在下生物材料中目标荧光团的成像
EP3203902B1 (en) 2014-10-09 2021-07-07 Novadaq Technologies ULC Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
CA3049922A1 (en) 2017-02-10 2018-08-16 Novadaq Technologies ULC Open-field handheld fluorescence imaging systems and methods
EP3412303A1 (en) 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3806592A (en) * 1970-12-18 1974-04-23 Rohm & Haas Method for evaluating bile sufficiency
CS255758B1 (en) * 1985-12-11 1988-03-15 Frantisek Rypacek Preparat for the diagnostic of transportion function of oviduct and process for preparing thereof
FI884721A7 (fi) * 1987-10-15 1989-04-16 Moskovsky Gosudarstvenny Univ Fluorijohdannnaisten käyttö varjoaineina
DE3812816A1 (de) * 1988-04-16 1989-11-02 Lawaczeck Ruediger Dipl Phys P Verfahren zur solubilisierung von liposomen und/oder biologischer membranen sowie deren verwendung
US5140463A (en) * 1990-03-08 1992-08-18 Yoo Kwong M Method and apparatus for improving the signal to noise ratio of an image formed of an object hidden in or behind a semi-opaque random media
NZ262679A (en) * 1993-02-22 1997-08-22 Vivorx Pharmaceuticals Inc Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell

Also Published As

Publication number Publication date
FI973208A7 (fi) 1997-10-01
NO973542D0 (no) 1997-08-01
WO1996023524A1 (en) 1996-08-08
HUP9900610A2 (hu) 1999-07-28
EP0808175B1 (en) 2002-07-31
GB9502065D0 (en) 1995-03-22
AU4545896A (en) 1996-08-21
JPH10513175A (ja) 1998-12-15
DE69622693D1 (de) 2002-09-05
CA2212257A1 (en) 1996-08-08
KR19980701880A (ko) 1998-06-25
EP0808175A1 (en) 1997-11-26
FI973208A0 (fi) 1997-08-01
FI973208L (fi) 1997-10-01
MX9705829A (es) 1997-11-29
JP4155596B2 (ja) 2008-09-24
DE69622693T2 (de) 2003-04-03
BR9607012A (pt) 1997-10-28
NO973542L (no) 1997-10-01
KR19987001880A (es) 1998-06-25

Similar Documents

Publication Publication Date Title
ES2182960T3 (es) Medio de contraste para la toma de imagenes in vivo basado en la transmision de la luz al reflejarse.
DE60127015D1 (de) Optisches Projektionssystem und dieses verwendende Projektionsanzeigevorrichtung
BR0101538A (pt) Espelho retrovisor para veìculos, especialmente para veìculos comerciais
ATE223581T1 (de) Bildanzeigevorrichtung
AU7221698A (en) Light imaging contrast agents
DE60040440D1 (de) Endoskop mit Lichtquelle
EP1333686A3 (en) Display system
BR9801160A (pt) Veículo automotor.
DE50204916D1 (de) Optisches Abbildungssystem mit Polarisationsmitteln
EP1171795A4 (en) ELECTROOPTIC, LIGHT-MODULATING DEVICE
BR9804488B1 (pt) filme para modulação de luz curável por radiação ultravioleta e método para sua obtenção.
BR9603913A (pt) Embreagem de fricção no ramal de acionamento de um automóvel
IT1296088B1 (it) Manipolo odontoiatrico con sorgente luminosa incorporata
DE60201630D1 (de) Optischer MEMS Schalter mit Abbildungssystem
DE60010548D1 (de) Projektor mit elektro-optischem Modulator und Prisma
DE60000166D1 (de) Lichtquelle mit Selbstüberwachung für wellenlängenstabile optische Nachrichtenübertragung
DE60116958D1 (de) Optisches Übertragungsmodul und dieses verwendendes optisches Übertragungssystem
FR2822311B1 (fr) Systeme de transmission optique
FR2760120B1 (fr) Systeme d'affichage pourvu d'une source lumineuse
NL1008436A1 (nl) Optische pickup-aandrijver.
GB0401190D0 (en) Optical system light source and projection display
DE69632182D1 (de) Hybridlinse und diese Hybridlinse verwendendes optisches Bilderzeugungssystem
BR0000074A (pt) Forquilha de engate com sapatas plásticas deslizantes
DE69827538D1 (de) Durchlichtbildanzeigevorrichtung
IT1315852B1 (it) Luce di segnalazione a campo illuminante omogeneo per autoveicolo.